VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CVS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CVSCVS Health Corp.
$85.81$109.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCVSFinancials

CVS Health Corp. (CVS) Income Statement

30Y historyFree accessUpdated daily

Revenue grew 5.4% to $108.4B in 2026Q3 while the combined ratio tightened to 96.7%, though the thin operating margin near 3.3% and the 2025Q3 net loss of $4.0B suggest profitability remains fragile.

Income StatementBalance SheetCash FlowRatios

CVS Income Statement

Annual statement

CVS Income Statement

CVS Health Corp. (CVS) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue420.61B402.07B372.81B357.78B322.47B292.11B268.71B256.78B194.58B184.79B177.55B153.29B139.37B126.76B123.12B107.08B95.78B98.22B87.47B76.33B43.82B37.01B30.59B26.59B24.18B22.24B20.09B18.1B15.27B13.75B11.83B
Revenue Growth %6.73%7.85%4.2%10.95%10.39%8.71%4.65%31.96%5.3%4.08%15.82%9.99%9.94%2.96%14.98%11.8%-2.48%12.28%14.6%74.18%18.41%20.96%15.07%9.95%8.72%10.72%10.99%18.49%11.08%16.21%21.18%
Medical Costs & Claims360.78B346.7B321.41B303.35B267.96B239.99B219.66B211.25B163.04B156.26B148.71B126.76B114B102.98B100.63B86.52B75.56B77.86B69.18B60.22B32.08B27.31B22.56B19.73B18.11B16.55B14.73B13.24B11.14B10.03B8.47B
Medical Cost Ratio %85.77%86.23%86.21%84.79%83.1%82.16%81.75%82.27%83.79%84.56%83.76%82.69%81.8%81.24%81.73%80.8%78.89%79.27%79.09%78.9%73.2%73.8%73.75%74.19%74.9%74.41%73.31%73.14%72.97%72.93%71.62%
Gross Profit59.84B55.36B51.4B54.43B54.5B52.12B49.05B45.53B31.54B28.53B28.83B26.53B25.37B23.78B22.49B20.56B20.22B20.36B18.29B16.11B11.74B9.69B8.03B6.86B6.07B5.69B5.36B4.86B4.13B3.72B3.36B
Gross Margin %14.23%13.77%13.79%15.21%16.9%17.84%18.25%17.73%16.21%15.44%16.24%17.31%18.2%18.76%18.27%19.2%21.11%20.73%20.91%21.1%26.8%26.2%26.25%25.81%25.1%25.59%26.69%26.86%27.03%27.07%28.38%
Gross Profit Growth %-7.71%-5.57%-0.13%4.57%6.27%7.73%44.36%10.55%-1.06%8.69%4.58%6.66%5.76%9.37%1.7%-0.68%11.31%13.55%37.18%21.12%20.71%17.02%13.09%6.64%6.14%10.29%17.73%10.92%10.85%15.64%
Operating Expenses44.78B44.98B42.88B40.69B46.55B38.81B35.13B33.54B27.52B18.99B18.45B17.05B16.57B15.75B15.28B14.23B14.08B13.93B12.24B11.31B9.3B7.68B6.58B5.44B4.86B4.92B4.04B3.73B3.2B3.02B2.75B
OpEx / Revenue %10.65%11.19%11.5%11.37%14.43%13.29%13.08%13.06%14.14%10.28%10.39%11.12%11.89%12.42%12.41%13.29%14.7%14.19%14%14.82%21.22%20.74%21.5%20.46%20.11%22.12%20.11%20.59%20.94%21.95%23.27%
Depreciation & Amortization4.52B4.61B4.6B4.37B4.22B4.49B4.44B4.37B2.72B2.48B2.48B2.09B1.93B1.87B1.75B1.57B1.47B1.39B1.27B1.09B733.3M589.1M439.9M341.7M310.3M320.8M296.6M277.9M249.7M242.6M262.8M
Combined Ratio %96.42%97.42%97.72%96.16%97.53%95.44%94.82%95.33%97.93%94.84%94.15%93.82%93.69%93.66%94.14%94.09%93.59%93.46%93.09%93.72%94.43%94.54%95.25%94.65%95.01%96.54%93.42%93.73%93.91%94.88%94.89%
Operating Income15.06B10.38B8.52B13.74B7.95B13.31B13.91B11.99B4.02B9.54B10.39B9.47B8.8B8.04B7.21B6.33B6.14B6.42B6.05B4.79B2.44B2.02B1.45B1.42B1.21B770.6M1.32B1.14B930.5M704.1M604.7M
Operating Margin %3.58%2.58%2.28%3.84%2.47%4.56%5.18%4.67%2.07%5.16%5.85%6.18%6.31%6.34%5.86%5.91%6.41%6.54%6.91%6.28%5.57%5.46%4.75%5.35%4.99%3.46%6.58%6.27%6.09%5.12%5.11%
Operating Income Growth %-21.95%-38.03%72.78%-40.24%-4.32%16.05%198.11%-57.84%-8.16%9.61%7.68%9.48%11.47%13.88%3.16%-4.48%6.27%26.13%96.32%20.9%38.83%2.18%18.02%56.53%-41.74%16.49%22.03%32.15%16.44%52.62%
EBITDA19.58B14.99B13.11B18.11B12.18B17.8B18.35B16.36B6.74B12.02B12.86B11.57B10.73B9.91B8.96B7.9B7.61B7.81B7.32B5.89B3.17B2.61B1.89B1.77B1.52B1.09B1.62B1.41B1.18B946.7M867.5M
EBITDA Margin %4.66%3.73%3.52%5.06%3.78%6.09%6.83%6.37%3.46%6.5%7.24%7.55%7.7%7.82%7.28%7.38%7.94%7.96%8.37%7.71%7.25%7.05%6.19%6.64%6.27%4.91%8.06%7.81%7.73%6.89%7.33%
Interest Expense3.06B3.12B2.96B2.66B2.29B2.5B2.91B3.04B2.62B1.06B1.08B859M615M517M561M588M539M530M530M000000000000
Non-Operating Income-122M5.13B-590M-88M-169M270M1.23B-45M-4M208M671M0506M-8M344M-4M-3M-5M-21M000000-352.5M00000
Pretax Income12.12B2.14B6.15B11.17B5.84B10.54B9.77B9B1.41B8.27B8.64B8.62B7.68B7.53B6.3B5.75B5.6B5.9B5.54B4.36B2.23B1.91B1.4B1.38B1.16B709.6M1.24B1.08B691M237.6M643.4M
Pretax Margin %2.88%0.53%1.65%3.12%1.81%3.61%3.64%3.5%0.72%4.47%4.86%5.62%5.51%5.94%5.12%5.37%5.85%6.01%6.33%5.71%5.08%5.16%4.56%5.17%4.78%3.19%6.19%5.95%4.52%1.73%5.44%
Income Tax1.09B408M1.56B2.81B1.51B2.55B2.57B2.37B2B1.64B3.32B3.39B3.03B2.93B2.44B2.26B2.18B2.2B2.19B1.72B856.9M684.3M477.6M528.2M439.2M296.4M497.4M441.3M306.5M149.2M271M
Effective Tax Rate %8.96%19.1%25.41%25.11%25.86%24.18%26.29%26.3%142.39%19.8%38.4%39.3%39.5%38.89%38.64%39.29%38.9%37.29%39.61%39.5%38.5%35.85%34.2%38.4%38%41.77%40%41%44.36%62.79%42.12%
Net Income11.05B1.77B4.61B8.34B4.31B8B7.18B6.63B-594M6.62B5.32B5.24B4.64B4.59B3.86B3.46B3.43B3.7B3.21B2.64B1.37B1.22B918.8M847.3M716.6M413.2M746M635.1M384.5M88.8M208.2M
Net Margin %2.63%0.44%1.24%2.33%1.34%2.74%2.67%2.58%-0.31%3.58%2.99%3.42%3.33%3.62%3.14%3.23%3.58%3.76%3.67%3.45%3.12%3.31%3%3.19%2.96%1.86%3.71%3.51%2.52%0.65%1.76%
Net Income Growth %2256.72%-61.68%-44.7%93.55%-46.12%11.45%8.22%1216.84%-108.97%24.54%1.53%12.77%1.13%18.84%11.61%1.02%-7.28%15.07%21.81%92.64%11.77%33.29%8.44%18.24%73.43%-44.61%17.46%65.18%333%-57.35%136.35%
EPS (Diluted)8.561.393.666.473.265.955.465.08-0.576.444.904.633.963.743.032.572.492.552.181.921.601.451.101.030.880.500.920.780.480.100.26
EPS Growth %2160.53%-62.02%-43.43%98.47%-45.21%8.97%7.48%991.23%-108.85%31.43%5.83%16.92%5.88%23.43%17.9%3.21%-2.35%16.97%13.54%20%10.34%31.82%6.8%17.05%76%-45.65%17.95%62.5%405.26%-63.46%117.11%
EPS (Basic)-1.403.666.493.296.005.485.10-0.576.474.934.663.983.773.052.592.512.582.231.971.651.491.131.060.900.510.940.800.480.100.27
Diluted Shares Outstanding1.29B1.27B1.26B1.29B1.32B1.33B1.31B1.3B1.04B1.02B1.08B1.13B1.17B1.23B1.28B1.35B1.38B1.45B1.47B1.37B853.2M841.6M822.36M808.45M810.6M797M799.34M817.8M810.4M790.53M426.4M

Key Metrics

Growth RegimeExpanding
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Regulatory scrutiny of vertical integration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Holds Near Mid-Single Digits

Based on EDBL's reported figures, CVS revenue reached $108.4B in 2026Q3 with year-over-year growth of 5.4%, decelerating from 8.4% in 2025Q2, suggesting top-line momentum is moderating from its earlier pace.

The revenue trajectory reflects a mature, scale-driven pharmacy and insurance base where growth is increasingly dependent on membership gains and PBM volume rather than pricing power. The deceleration from high-single-digit rates through 2025 suggests the expansion is maturing, and investors should monitor whether Medicare Advantage membership growth can offset softer retail traffic. Sustained growth below 6% would indicate the integrated model is increasingly reliant on acquisitions to sustain top-line expansion.

Combined Ratio Tightens But Stays Near 100%

As reported in financial statements, CVS combined ratio improved to 96.7% in 2026Q3 from 103.1% in 2025Q3, indicating underwriting results have moved closer to breakeven after a quarter of significant strain.

A combined ratio consistently in the mid-90s leaves a thin underwriting margin, meaning the insurance arm contributes limited cushion against medical cost volatility. The loss ratio of 86.3% in 2026Q3 is elevated relative to earlier periods, which may reflect senior utilization pressure noted in the reported risk profile. Investors should watch whether the recent improvement reflects durable cost containment or a temporary utilization lull.

Earnings Volatility Tied to Reserve Quality

According to recent SEC filings, CVS net income swung from a $4.0B loss in 2025Q3 to $2.2B profit in 2026Q3, a pattern that may partly reflect reserve adjustments and warrants further investigation.

The sharp quarterly swings in net income relative to comparatively stable revenue suggest that reserve development and one-time items are driving a meaningful share of reported earnings. Because the reported figures do not isolate prior-year development, the degree to which earnings are inflated or depressed by reserve changes cannot be confirmed from the data provided. Analysts should seek the prior-year development disclosure to assess whether current profitability is structurally sustainable.

Thin Operating Margin Limits Capital Flexibility

Based on reported figures, CVS operating income of $3.6B on $108.4B revenue in 2026Q3 implies an operating margin near 3.3%, leaving limited cushion given debt-to-equity of 1.24.

A margin of this magnitude provides little buffer against rising medical costs or integration expenses from recent acquisitions. Combined with elevated leverage, the company has less room to absorb an adverse utilization shock without pressure on debt service or dividend capacity. Investors should monitor whether operating income growth can keep pace with interest obligations.

Earnings Beat May Reflect Non-Recurring Items

As reported in financial statements, the 2026Q3 EPS of $2.2B net income against a 0.4% net margin suggests the earnings beat could be driven by items that do not repeat, warranting caution.

The gap between a strong EPS beat and a net margin near 0.4% suggests that headline earnings may be sensitive to a small number of large items rather than broad operating improvement. If the beat reflects reserve releases or timing effects, the apparent momentum may not persist into subsequent quarters. Investors should treat the raised guidance as provisional until margin improvement is confirmed across multiple periods.

CVS — Frequently Asked Questions

Quick answers to the most common questions about buying CVS stock.

What was CVS Health Corp.'s (CVS) revenue in 2025?

For fiscal year 2025, CVS Health Corp. (CVS) reported total revenue of $402.07B. This represents a 3298.2% increase compared to $11.83B in 1996.

Is CVS Health Corp. (CVS) profitable?

CVS Health Corp. (CVS) is profitable, generating $1.77B in net income for the fiscal year ending 2025 with a net profit margin of 0.4%.

What is CVS Health Corp.'s operating profit margin?

CVS Health Corp. (CVS) reported an operating income of $10.38B, resulting in an operating profit margin of 2.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is CVS Health Corp.'s gross profit and gross margin?

CVS Health Corp. (CVS) generated $55.36B in gross profit for the year, representing a gross profit margin of 13.8%. This demonstrates the company's core pricing power and production efficiency.